2022 saw the highest ever uptake of HIV testing among gay, bisexual, and other men who have sex with men (GBMSM), with diagnoses in this group continuing to fall, according to the latest HIV surveillance update for the UK.
Adicet follows other cell therapy biotechs in autoimmune pivot
Adicet Bio is shelving plans to use its lead asset to treat cancer and instead shifting its target to autoimmune diseases. The move, disclosed by